<DOC>
	<DOCNO>NCT01651052</DOCNO>
	<brief_summary>The purpose observational trial gather clinical data confirm safety performance Edwards Pericardial Aortic Bioprosthesis , Model 11000 trial population .</brief_summary>
	<brief_title>Clinical Trial Edwards Aortic Bioprosthesis , Model 11000</brief_title>
	<detailed_description>This prospective , non-randomized , non-controlled observational clinical trial . Up 200 subject enrol 6 participate clinical site . The trial include male female patient , 18 year old , require replacement diseased , damage , malfunction native prosthetic valve . Patients follow assessed implant 5 year .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<criteria>18 year old Require replacement aortic valve Signed informed consent Willing return study site followup visit Active endocarditis/myocarditis ( &lt; 3 month ) Myocardial infarction ( &lt; 30 day ) Renal insufficiency/ Endstage renal disease Life expectancy ( &lt; 1 year ) Requires multiple valve replacement/repair Requiring emergent aortic valve surgery Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Aortic valve replacement/regurgitation</keyword>
</DOC>